Bharat Parenterals receives license for Favipiravir Oral Suspension
The product patent has been already filed under fast track approval
The product patent has been already filed under fast track approval
The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield
Subscribe To Our Newsletter & Stay Updated